A Phase 1 trial found that combining the ATR inhibitor ceralasertib with the PARP inhibitor olaparib was generally well ...

I have completed a master's degree in a science-related graduate school and work as a researcher at a manufacturing company.

A routine blood draw may one day help catch one of the world’s most common kidney cancers before it spreads, according to a study published in Epigenetics Communications. Researchers in Japan report t ...

Chroma Bio's CRMA-1001 epigenetic silencer therapy demonstrates sustained HBV suppression in preclinical models. Read the ...

Anthropic's Claude AI discovers a novel enzyme system in bacterial DNA, marking a breakthrough in AI-assisted genomic ...

A record player-like microscope and computer simulations solve a longtime mystery, showing that metal ions bridge DNA strands ...

It is too soon to say that Claude – or the team of human researchers involved – has discovered a “new CRISPR”. But the result does show us something about how AI is beginning to work in science, with ...

AI giant Anthropic has announced the discovery of a new enzyme system in bacterial DNA that it said could “represent a new gene editing mechanism” similar to the groundbreaking CRISPR tool. Anthropic ...

Ginkgo Bioworks Holdings, Inc. (DNA) closed at $7.06 in the latest trading session, marking a +1% move from the prior day. This move outpaced the S&P 500's daily loss of 0.45%. Elsewhere, the Dow lost ...

DNA molecules should repel one another because their backbones carry the same negative charge. Yet inside cells, DNA routinely has to approach and recognize other DNA. That happens during processes ...